Cargando…

Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers

Lynch syndrome is mostly characterized by early-onset colorectal and endometrial adenocarcinomas. Over 90% of the causal mutations occur in two mismatch repair genes, MSH2 and MLH1. The aim of this study was to evaluate the age-dependent cancer risk in MSH2 or MLH1 mutation carriers from data of DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Olschwang, Sylviane, Yu, Kai, Lasset, Christine, Baert-Desurmont, Stéphanie, Buisine, Marie-Pierre, Wang, Qing, Hutter, Pierre, Rouleau, Etienne, Caron, Olivier, Bourdon, Violaine, Thomas, Gilles
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859022/
https://www.ncbi.nlm.nih.gov/pubmed/20445804
http://dx.doi.org/10.1155/2009/791754
_version_ 1782180472348999680
author Olschwang, Sylviane
Yu, Kai
Lasset, Christine
Baert-Desurmont, Stéphanie
Buisine, Marie-Pierre
Wang, Qing
Hutter, Pierre
Rouleau, Etienne
Caron, Olivier
Bourdon, Violaine
Thomas, Gilles
author_facet Olschwang, Sylviane
Yu, Kai
Lasset, Christine
Baert-Desurmont, Stéphanie
Buisine, Marie-Pierre
Wang, Qing
Hutter, Pierre
Rouleau, Etienne
Caron, Olivier
Bourdon, Violaine
Thomas, Gilles
author_sort Olschwang, Sylviane
collection PubMed
description Lynch syndrome is mostly characterized by early-onset colorectal and endometrial adenocarcinomas. Over 90% of the causal mutations occur in two mismatch repair genes, MSH2 and MLH1. The aim of this study was to evaluate the age-dependent cancer risk in MSH2 or MLH1 mutation carriers from data of DNA diagnostic laboratories. To avoid overestimation, evaluation was based on the age-dependent proportion of mutation carriers in asymptomatic first-degree relatives of identified mutation carriers. Data from 859 such eligible relatives were collected from 8 centers; 387 were found to have inherited the mutation from their relatives. Age-dependent risks were calculated either using a nonparametric approach for four discrete age groups or assuming a modified Weibull distribution for the dependence of risk on age. Cancer risk was estimated starting at 28 (25–32 0.68 confidence interval) and to reach near 0.70 at 70 years. The risks were very similar for MSH2 and MLH1 mutation carriers. Although not statistically significant, the risk in males appeared to precede that for females by ten years. This difference needs to be investigated on a larger dataset. If confirmed, this would indicate that the onset of the colonoscopic surveillance may be different in male and female mutation carriers.
format Text
id pubmed-2859022
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28590222010-05-05 Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers Olschwang, Sylviane Yu, Kai Lasset, Christine Baert-Desurmont, Stéphanie Buisine, Marie-Pierre Wang, Qing Hutter, Pierre Rouleau, Etienne Caron, Olivier Bourdon, Violaine Thomas, Gilles J Cancer Epidemiol Research Article Lynch syndrome is mostly characterized by early-onset colorectal and endometrial adenocarcinomas. Over 90% of the causal mutations occur in two mismatch repair genes, MSH2 and MLH1. The aim of this study was to evaluate the age-dependent cancer risk in MSH2 or MLH1 mutation carriers from data of DNA diagnostic laboratories. To avoid overestimation, evaluation was based on the age-dependent proportion of mutation carriers in asymptomatic first-degree relatives of identified mutation carriers. Data from 859 such eligible relatives were collected from 8 centers; 387 were found to have inherited the mutation from their relatives. Age-dependent risks were calculated either using a nonparametric approach for four discrete age groups or assuming a modified Weibull distribution for the dependence of risk on age. Cancer risk was estimated starting at 28 (25–32 0.68 confidence interval) and to reach near 0.70 at 70 years. The risks were very similar for MSH2 and MLH1 mutation carriers. Although not statistically significant, the risk in males appeared to precede that for females by ten years. This difference needs to be investigated on a larger dataset. If confirmed, this would indicate that the onset of the colonoscopic surveillance may be different in male and female mutation carriers. Hindawi Publishing Corporation 2009 2009-03-08 /pmc/articles/PMC2859022/ /pubmed/20445804 http://dx.doi.org/10.1155/2009/791754 Text en Copyright © 2009 Sylviane Olschwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Olschwang, Sylviane
Yu, Kai
Lasset, Christine
Baert-Desurmont, Stéphanie
Buisine, Marie-Pierre
Wang, Qing
Hutter, Pierre
Rouleau, Etienne
Caron, Olivier
Bourdon, Violaine
Thomas, Gilles
Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title_full Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title_fullStr Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title_full_unstemmed Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title_short Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
title_sort age-dependent cancer risk is not different in between msh2 and mlh1 mutation carriers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859022/
https://www.ncbi.nlm.nih.gov/pubmed/20445804
http://dx.doi.org/10.1155/2009/791754
work_keys_str_mv AT olschwangsylviane agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT yukai agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT lassetchristine agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT baertdesurmontstephanie agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT buisinemariepierre agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT wangqing agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT hutterpierre agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT rouleauetienne agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT caronolivier agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT bourdonviolaine agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers
AT thomasgilles agedependentcancerriskisnotdifferentinbetweenmsh2andmlh1mutationcarriers